Direkt zum Inhalt

Michaelides, Ioannis ; Künzel, Julian ; Ettl, Tobias ; Beckhove, Philipp ; Bohr, Christopher ; Brochhausen, Christoph ; Mamilos, Andreas

Adenoid cystic carcinoma of the salivary glands: a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis

Michaelides, Ioannis , Künzel, Julian , Ettl, Tobias , Beckhove, Philipp , Bohr, Christopher, Brochhausen, Christoph und Mamilos, Andreas (2023) Adenoid cystic carcinoma of the salivary glands: a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis. European Archives of Oto-Rhino-Laryngology 280, S. 2937-2944.

Veröffentlichungsdatum dieses Volltextes: 08 Mrz 2023 06:48
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.53893


Zusammenfassung

BackgroundAdenoid cystic carcinoma (ACC) is a rare type of cancer commonly occurring in salivary glands. It is characterized by slow but infiltrative growth, nerve infiltration and overall poor prognosis, with late recurrence and distant metastasis. The treatment of ACC is still limited to surgery and/or (adjuvant) radiotherapy. Till now no promising systemic therapy option exists. However, ...

BackgroundAdenoid cystic carcinoma (ACC) is a rare type of cancer commonly occurring in salivary glands. It is characterized by slow but infiltrative growth, nerve infiltration and overall poor prognosis, with late recurrence and distant metastasis. The treatment of ACC is still limited to surgery and/or (adjuvant) radiotherapy. Till now no promising systemic therapy option exists. However, various studies deliver promising results after treatment with anti-angiogenetic agents, such as anti-EGFR-antibody Cetuximab or Tyrosinkinase inhibitor Lenvatinib.MethodsBy using of immunohistological methods we analyzed and compared the macrophage and lymphocyte populations, vascularization, and PD-L1-status in 12 ACC of the salivary glands.ResultsAll cases showed a significant elevation of macrophages with M2 polarization and a higher vascularization in ACC compared to normal salivary gland tissue. The CD4/CD8 quotient was heterogenous. ACC does not show relevant PD-L1 expression.ConclusionsThe predominant M2 polarization of macrophages in ACC could be responsible for elevated vascularization, as already been proved in other cancer types, that M2 macrophages promote angiogenesis.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftEuropean Archives of Oto-Rhino-Laryngology
Verlag:SPRINGER
Ort der Veröffentlichung:NEW YORK
Band:280
Seitenbereich:S. 2937-2944
Datum1 März 2023
InstitutionenMedizin > Lehrstuhl für Hals-Nasen-Ohren-Heilkunde
Medizin > Lehrstuhl für Mund-, Kiefer- und Gesichtschirurgie
Medizin > Lehrstuhl für Pathologie
Leibniz-Institut für Immuntherapie (LIT)
Identifikationsnummer
WertTyp
10.1007/s00405-023-07884-3DOI
Stichwörter / KeywordsPHASE-II; MACROPHAGES; CHEMOTHERAPY; SORAFENIB; CETUXIMAB; RECURRENT; HEAD; Adenoid cystic carcinoma; Macrophage polarization; Neovascularization; Salivary gland cancer
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenZum Teil
URN der UB Regensburgurn:nbn:de:bvb:355-epub-538937
Dokumenten-ID53893

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben